Does Dr. IULIANA SHAPIRA have financial conflicts of interest?

Dr. IULIANA SHAPIRA (MD) has received a total of $43,237 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $41,155 in personal promotional payouts (consulting, meals, travel) and $2,082 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. IULIANA SHAPIRA?

According to CMS Open Payments data, Dr. IULIANA SHAPIRA received funding from DAIICHI SANKYO ($11,981), ASTRAZENECA PHARMACEUTICALS ($4,115), and BEIGENE USA ($3,375).

Does Dr. IULIANA SHAPIRA receive research grants or speaking fees?

Dr. IULIANA SHAPIRA has received $41,155 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $2,082 in clinical research grants.

DR. IULIANA SHAPIRA

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: LITTLE SILVER, NJ 07739

NPI Number: 1760553762

LIFETIME INDUSTRY VALUE

$43,237

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. SHAPIRA is a verified Internal Medicine, Hematology & Oncology practitioner based in LITTLE SILVER, NJ.

Between 2021 and 2025, Dr. SHAPIRA had an overall industry promotional and research financial footprint of $43,237 as recorded in the federal CMS Open Payments database.

$41,155 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$2,082 was allocated to sponsored clinical trials and medical research activities.

Dr. SHAPIRA's primary funding source is DAIICHI SANKYO, which accounts for $11,981 (representing 27.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

DAIICHI SANKYO

Rank 1

$11,981

27.7%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$4,115

9.5%

BEIGENE USA

Rank 3

$3,375

7.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.